US Patent 12024484 Lipid formulations for gene editing
Patent 12024484 was granted and assigned to Verve Therapeutics on July, 2024 by the United States Patent and Trademark Office.
Name
# Contributions
Last Contribution
Find more entities like US Patent 12024484 Lipid formulations for gene editing
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
